The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion
- PMID: 31003453
- PMCID: PMC6515232
- DOI: 10.3390/ijms20081913
The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion
Abstract
Background: Helicobacter pylori (H. pylori) eradication therapy may improve gastric atrophy and intestinal metaplasia, but the results of previous studies have not always been consistent. The aim of this study was to compare the histological changes of intestinal metaplasia and gastric atrophy among the use of acid-suppressing drugs after H. pylori eradication.
Methods: A cohort of 242 patients who underwent successful eradication therapy for H. pylori gastritis and surveillance endoscopy examination from 1996 to 2015 was analyzed. Changes in the histological scores of intestinal metaplasia and atrophy according to drug use (proton-pump inhibitors (PPIs), H2 receptor antagonists (H2RAs), and non-acid suppressant use) were evaluated in biopsies of the antrum and corpus using a generalized linear mixed model in all patients.
Results: The mean follow-up period and number of biopsies were 5.48 ± 4.69 years and 2.62 ± 1.67 times, respectively. Improvement in the atrophy scores of both the antrum (p = 0.042) and corpus (p = 0.020) were significantly superior in patients with non-acid suppressant drug use compared with those of PPI and H2RA use. Metaplasia scores in both the antrum and corpus did not improve in all groups, and no significant differences were observed among groups in the antrum (p = 0.271) and corpus (p = 0.077).
Conclusions: Prolonged acid suppression by PPIs or H2RAs may limit the recovery of gastric atrophy following H. pylori eradication.
Keywords: H. pylori eradication; atrophy; proton pump inhibitors (PPIs).
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.World J Gastroenterol. 2015 Apr 21;21(15):4599-606. doi: 10.3748/wjg.v21.i15.4599. World J Gastroenterol. 2015. PMID: 25914469 Free PMC article.
-
The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.Hepatogastroenterology. 1999 May-Jun;46(27):2048-56. Hepatogastroenterology. 1999. PMID: 10430396 Clinical Trial.
-
Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.Scand J Gastroenterol. 2013 Nov;48(11):1249-56. doi: 10.3109/00365521.2013.838994. Epub 2013 Sep 30. Scand J Gastroenterol. 2013. PMID: 24079881
-
Characteristics and predictors of gastric cancer after Helicobacter pylori eradication.World J Gastroenterol. 2018 May 28;24(20):2163-2172. doi: 10.3748/wjg.v24.i20.2163. World J Gastroenterol. 2018. PMID: 29853734 Free PMC article. Review.
-
Helicobacter pylori eradication and associated changes in the gastric mucosa.Expert Rev Anti Infect Ther. 2005 Oct;3(5):757-64. doi: 10.1586/14787210.3.5.757. Expert Rev Anti Infect Ther. 2005. PMID: 16207167 Review.
Cited by
-
Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective.BMJ Open Gastroenterol. 2025 Apr 19;12(1):e001719. doi: 10.1136/bmjgast-2024-001719. BMJ Open Gastroenterol. 2025. PMID: 40253055 Free PMC article.
-
Chinese integrated guideline on the management of gastric precancerous conditions and lesions.Chin Med. 2022 Dec 14;17(1):138. doi: 10.1186/s13020-022-00677-6. Chin Med. 2022. PMID: 36517854 Free PMC article. Review.
-
Association between the chronic use of gastric acid suppressants and high-risk colorectal polyps.JGH Open. 2021 Jan 29;5(3):371-376. doi: 10.1002/jgh3.12503. eCollection 2021 Mar. JGH Open. 2021. PMID: 33732884 Free PMC article.
-
The role of gastric mucins and mucin-related glycans in gastric cancers.Cancer Sci. 2024 Sep;115(9):2853-2861. doi: 10.1111/cas.16282. Epub 2024 Jul 19. Cancer Sci. 2024. PMID: 39031976 Free PMC article. Review.
-
Non-Helicobacter pylori Gastric Microbiome Modulates Prooncogenic Responses and Is Associated With Gastric Cancer Risk.Gastro Hep Adv. 2023 Mar 12;2(5):684-700. doi: 10.1016/j.gastha.2023.03.010. eCollection 2023. Gastro Hep Adv. 2023. PMID: 39129877 Free PMC article.
References
-
- Shichijo S., Hirata Y., Niikura R., Hayakawa Y., Yamada A., Ushiku T., Fukayama M., Koike K. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after helicobacter pylori eradication. Gastrointest. Endosc. 2016;84:618–624. doi: 10.1016/j.gie.2016.03.791. - DOI - PubMed
-
- Toyokawa T., Suwaki K., Miyake Y., Nakatsu M., Ando M. Eradication of helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long-term prospective cohort study. J. Gastroenterol. Hepatol. 2010;25:544–547. doi: 10.1111/j.1440-1746.2009.05995.x. - DOI - PubMed
-
- Rocco A., Suriani R., Cardesi E., Venturini I., Mazzucco D., Nardone G. Gastric atrophy and intestinal metaplasia changes 8 years after helicobacter pylori eradication. A blind, randomised study. Minerva Gastroenterol. Dietol. 2002;48:175–178. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical